Evidence map›Paper›PMID 26675476›Full record

ArticleBBA clinical2014

Cells from the skin of patients with systemic sclerosis secrete chitinase 3-like protein 1.

Yuen Yee Ho, Murray Baron, Anneliese D Recklies, Peter J Roughley, John S Mort

Open access · hybridAbstract read
In one paragraph

Article in BBA clinical, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. MKP-1 Deficiency Exacerbates Skin Fibrosis in a Mouse Model of Scleroderma.International journal of molecular sciences · 2023
    Article
  5. Article
  6. Oncostatin M and its role in fibrosis.Connective tissue research · 2019
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yuen Yee HoShriners Hospital for Children, Department of Surgery, McGill University, 1529 Cedar Avenue, Montréal, Quebec H3G 1A6, Canada.
Murray BaronDepartment of Rheumatology, Jewish General Hospital, 3755 Cote Ste Catherine Road, Montréal, Quebec H3T 1E2, Canada.
Anneliese D ReckliesShriners Hospital for Children, Department of Surgery, McGill University, 1529 Cedar Avenue, Montréal, Quebec H3G 1A6, Canada.
Peter J RoughleyShriners Hospital for Children, Department of Surgery, McGill University, 1529 Cedar Avenue, Montréal, Quebec H3G 1A6, Canada.
John S MortShriners Hospital for Children, Department of Surgery, McGill University, 1529 Cedar Avenue, Montréal, Quebec H3G 1A6, Canada.
McGill University · CAJewish General Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe chitinase-like protein, Chi3L1, is associated with increased fibrotic activity as well as inflammatory processes. The capacity of skin cells from systemic sclerosis (SSc) patients to produce Chi3L1, and the stimulation of its synthesis by cytokines or growth factors known to be associated with SSc, was investigated.

methodsCells were isolated from forearm and/or abdomen skin biopsies taken from SSc patients and normal individuals and stimulated with cytokines and growth factors to assess Chi3L1 expression. Chi3L1-expressing cells were characterized by immunohistochemical staining.

resultsChi3L1 was not secreted by skin cells from normal individuals nor was its synthesis induced by any of the cytokines or growth factors investigated. In contrast, Chi3L1 secretion was induced by OSM or IL-1 in cells from all forearm biopsies of SSc patients, and endogenous secretion in the absence of cytokines was detected in several specimens. Patients with Chi3L1-producing cells at both the arm and abdomen had a disease duration of less than 3 years. Endogenous Chi3L1 production was not a property of the major fibroblast population nor of myofibroblasts, but rather was related to the presence of stem-like cells not present in normal skin. Other cells, however, contributed to the upregulation of Chi3L1 by OSM.

conclusionsThe emergence of cells primed to respond to OSM with increased Chi3L1 production appears to be associated with pathological processes active in SSc. GENERAL SIGNIFICANCE: The presence of progenitor cells expressing the chilectin Chi3L1 in SSc skin appears to play a role in the initiation of the disease process.

Indexed as

Chi3L1, chitinase 3-like protein 1Chitinase 3-like protein 1CytokineDAPI, 4′,6-diamidino-2-phenylindoleECM, extracellular matrixIL, interleukinmRSS, modified Rodnan skin scoreOncostatin MOSM, oncostatin MPDGF, platelet-derived growth factorSBTI, soybean trypsin inhibitorSclerodermaSSc, systemic sclerosis (scleroderma)Stem cellSystemic sclerosisTGFβ, transforming growth factor-βTIE2, tyrosine kinase with Ig and EGF homology domains-2αSMA, α-smooth muscle actin

Identifiers

PMID26675476
PMCPMC4633946
OpenAlexW2048409940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.